These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 9257428

  • 1. Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) study.
    Cascinu S, Barni S, Labianca R, Del Ferro E, Rocchi MB, Ligi M, Pessi MA, Cazzaniga M, Zamparelli G, Ardizzoia A, Ugolini G, Ghiandoni G, Luporini G, Catalano G.
    Support Care Cancer; 1997 Jul; 5(4):314-7. PubMed ID: 9257428
    [Abstract] [Full Text] [Related]

  • 2. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.
    Buroker TR, O'Connell MJ, Wieand HS, Krook JE, Gerstner JB, Mailliard JA, Schaefer PL, Levitt R, Kardinal CG, Gesme DH.
    J Clin Oncol; 1994 Jan; 12(1):14-20. PubMed ID: 7677801
    [Abstract] [Full Text] [Related]

  • 3. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.
    Poon MA, O'Connell MJ, Wieand HS, Krook JE, Gerstner JB, Tschetter LK, Levitt R, Kardinal CG, Mailliard JA.
    J Clin Oncol; 1991 Nov; 9(11):1967-72. PubMed ID: 1941055
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Colonic methane production modifies gastrointestinal toxicity associated with adjuvant 5-fluorouracil chemotherapy for colorectal cancer.
    Holma R, Korpela R, Sairanen U, Blom M, Rautio M, Poussa T, Saxelin M, Osterlund P.
    J Clin Gastroenterol; 2013 Jan; 47(1):45-51. PubMed ID: 23090038
    [Abstract] [Full Text] [Related]

  • 7. High-dose loperamide in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients.
    Cascinu S, Bichisao E, Amadori D, Silingardi V, Giordani P, Sansoni E, Luppi G, Catalano V, Agostinelli R, Catalano G.
    Support Care Cancer; 2000 Jan; 8(1):65-7. PubMed ID: 10650901
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
    Carlomagno C, Lauria R, De Laurentiis M, Arpino G, Massarelli E, Ferrara C, Milano A, Vernaglia Lombardi A, Costanzo R, Catalano G, Bianco AR, De Placido S.
    Oncology; 2002 Jan; 63(3):219-25. PubMed ID: 12381900
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Amifostine, in a reduced dose, protects against severe diarrhea associated with weekly fluorouracil and folinic acid chemotherapy in advanced colorectal cancer: a pilot study.
    Tsavaris N, Kosmas C, Vadiaka M, Zonios D, Papalambros E, Papantoniou N, Margaris H, Zografos G, Rokana S, Retalis G, Koufos C.
    J Pain Symptom Manage; 2003 Sep; 26(3):849-54. PubMed ID: 12967734
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Retrospective comparative analysis of 5FU + low-dose folinic acid vs. 5FU + high-dose folinic acid in the treatment of metastatic colorectal cancer. The Ottawa experience.
    Maroun JA, Cripps C, Goel R, Dahrouge S, Boisvert D.
    Am J Clin Oncol; 1997 Aug; 20(4):387-92. PubMed ID: 9256896
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD).
    Aranda E, Cervantes A, Carrato A, Antón-Torres A, Massutí T, Fernández-Martos C, Díaz-Rubio E.
    J Infus Chemother; 1996 Aug; 6(3):118-22. PubMed ID: 9229321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.